Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
Synthetic N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide or MDP) represents the smallest unit that can substitute for whole Mycobacteria in Freund's complete adjuvant. In this paper the fate of 14C-labelled (on the muramyl moiety) MDP is reported. Following intravenous or subcutaneous injection into mice, more than 50% of 14C-MDP was recovered in the urine after 30 min and more than 90% after 2 h. The labelled compound was found unchanged in the urine, as shown by detailed analyses. However, MDP was sequestered for a longer time at the site of injection when administered as a water-in-oil emulsion. Considering the relatively rapid elimination observed, it is suggested that the biological effects of MDP and related compounds, when administered in an aqueous medium, may be due to their activity at minute concentrations and/or an immediate action at the cellular level.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D001711:Biotransformation; D005260:Female; D005620:Freund's Adjuvant / Q000494:pharmacology; D006020:Glycopeptides / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D051379:Mice; D014018:Tissue Distribution
D006020:Glycopeptides; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D005620:Freund's Adjuvant